Refine
Has Fulltext
- yes (122)
Is part of the Bibliography
- yes (122)
Year of publication
Document Type
- Journal article (85)
- Doctoral Thesis (36)
- Preprint (1)
Language
- English (122) (remove)
Keywords
- melt electrowriting (13)
- 3D printing (12)
- additive manufacturing (10)
- biofabrication (9)
- hyaluronic acid (7)
- melt electrospinning writing (7)
- Hydrogel (6)
- bioprinting (6)
- 3D-Druck (5)
- bioink (5)
- polycaprolactone (5)
- tissue engineering (5)
- Polymere (4)
- Tissue Engineering (4)
- hydrogel (4)
- hydrogels (4)
- magnesium phosphate cement (4)
- phytic acid (4)
- scaffold (4)
- thiol-ene (4)
- Biofabrication (3)
- Biomaterial (3)
- Calciumphosphate (3)
- Knochenzement (3)
- biomaterials (3)
- bone (3)
- breast cancer (3)
- calcium phosphate cement (3)
- chondrogenic differentiation (3)
- electrohydrodynamics (3)
- extracellular matrix (3)
- melt electrowriting (MEW) (3)
- 3D powder printing (2)
- Calciumphosphat (2)
- Cement (2)
- Dihydrooxazole (2)
- Electrospinning (2)
- Fluorescence Microscopy (2)
- Knochenersatz (2)
- MSC (2)
- Melt Electrowriting (2)
- Melt electrowriting (2)
- Nanopartikel (2)
- Oberflächenfunktionalisierung (2)
- Polyethylenglykole (2)
- Polyoxazoline (2)
- Ringöffnungspolymerisation (2)
- Tissue engineering (2)
- Zement (2)
- angiogenesis (2)
- arteriovenous loop (2)
- baghdadite (2)
- biocompatibility (2)
- biomedical materials (2)
- bone adhesive (2)
- bone cement (2)
- calcium phosphate (2)
- cartilage (2)
- cortical neurons (2)
- dual setting (2)
- dual setting system (2)
- dual-stage crosslinking (2)
- electrohydrodynamic (2)
- in vitro (2)
- inflammation (2)
- polymer processing (2)
- polymer-peptide-conjugate (2)
- printability (2)
- rheology (2)
- shape fidelity (2)
- therapy (2)
- (AB)\(_{n}\) segmented copolymers (1)
- 2-Aminoethylphosphonic acid (1)
- 316L stainless-steel (1)
- 3D Bioprinting (1)
- 3D Printing (1)
- 3D cultures (1)
- 3D electrophysiology (1)
- 3D microfiber (1)
- 3D model systems (1)
- 3D neuronal networks (1)
- 3D scaffolds (1)
- 3D tumor model (1)
- ACPC (1)
- ALI culture (1)
- Additive Fertigung (1)
- Adenovirus (1)
- Adhäsion (1)
- Adipose Tissue (1)
- Anisotropic structures (1)
- Arteriosklerose (1)
- Artery Models (1)
- Aspergillose (1)
- Aspergillosis (1)
- Atherosclerosis (1)
- Baghdadite (1)
- Beschichtung (1)
- Biofabrication of hydrogels (1)
- Biofabrikation (1)
- Bioink (1)
- Biologischer Abbau (1)
- Blockcopolymere (1)
- Bone marrow (1)
- Bone-replacement (1)
- Breast cancer (1)
- Ca\(^{2+}\)-Imaging (1)
- Calcium Phosphate (1)
- Calcium phosphate (1)
- Calcium phosphate-based biomaterials (1)
- Calciumhydroxid (1)
- Calciumphosphatzemente (1)
- Cartilage (1)
- Cell Sheet Engineering (1)
- Cell adhesion (1)
- Ceramic polymer composite (1)
- Chelatbildner (1)
- Chemical modification of biopolymers (1)
- Chondrogenesis (1)
- Chondrogenic differentiation (1)
- Chondrozyten (1)
- Colloidal Stability (1)
- Correlative microscopy (1)
- Dectin-1 (1)
- Degradation (1)
- Dual setting system (1)
- Dual-setting (1)
- ECM (1)
- Elektrospinnen (1)
- Elektrostatisches Verspinnen (1)
- Extrazelluläre Matrix (1)
- Fettgewebe (1)
- Fibrin (1)
- Fibroblasten (1)
- FluidFM (1)
- FluidFM technology (1)
- Freezing (1)
- Functional hydrophilic polymers (1)
- Funktionalisierung <Chemie> (1)
- Funktionalisierung von elektrogesponnenen Fasern (1)
- Gefrierstrukturierung (1)
- Gelatine (1)
- Gene therapy (1)
- Gerichtete Erstarrung (1)
- Gewebe (1)
- Geweberegeneration (1)
- Glycidol (1)
- Gold-Nanoparticles (1)
- HA modifiedCNF membranes (1)
- HASH (1)
- HEMA (1)
- Hemodynamics (1)
- Hyaluronic Acid (1)
- Hyaluronsäure (1)
- Hypertrophy (1)
- Hämodynamik (1)
- IP6 (1)
- Implantat (1)
- In vitro model (1)
- Injectability (1)
- Iron Oxide Nanoparticles (1)
- Isocyanate (1)
- Janus fibers (1)
- Knochen (1)
- Knochenkleber (1)
- Knochenwachs (1)
- Knochenzemente (1)
- Knorpel (1)
- Konjugate (1)
- Korrelative Mikroskopie (1)
- MPI (1)
- MPS (1)
- MRI (1)
- Macrophage extracellular traps (1)
- Magnesiumphosphate (1)
- Makrophagen (1)
- Melt electrospinning (1)
- Mesenchymal stem cell (1)
- Modification (1)
- Modifikation von Biokeramiken (1)
- Morphology (1)
- Multifunctionalisability (1)
- NCO-sP(EO-stat-PO) (1)
- NLRP3 (1)
- Nanofaser (1)
- Nanogels (1)
- Nanoröhre (1)
- Nanotubular coatings (1)
- Nanotubuläre Beschichtungen (1)
- Normal breast (1)
- Oxygen diffusion hardening (1)
- PCL (1)
- PEG (1)
- PLGA (1)
- PTEN (1)
- PVD Beschichtung (1)
- PVD coatings (1)
- PVD-Verfahren (1)
- Poly(2-oxazoline) (1)
- Poly(glycidol)s (1)
- Polycaprolacton (1)
- Polylactid-co-Glycolid (1)
- Polymer-peptide-conjugate (1)
- Polymers (1)
- Polymilchsäure (1)
- Polyoxazolines (1)
- Primary cell lines (1)
- QCM (1)
- RAFT (1)
- RHO (1)
- ROCK (1)
- Rapid Prototyping <Fertigung> (1)
- Regeneration (1)
- Rheology (1)
- SOX9 (1)
- Sauerstoffdiffusionshärtung (1)
- Scaffold (1)
- Scaffold <Tissue Engineering> (1)
- Schiff base chemistry (1)
- Schleuderguss (1)
- Setting Control (1)
- Silica precursor (1)
- Sol-gel (1)
- Staphylococcus aureus / drug effects (1)
- Star-shaped poly(ethylene glycol) (1)
- Stem cells plasticity (1)
- Sternpolymere (1)
- Tantal (1)
- Therapeutisches System (1)
- Thermoresponsive Polymere (1)
- Thioether-Poly(glycidol) (1)
- Ti(Ag) Beschichtungen (1)
- Ti(Ag) coatings (1)
- Unidirectional Freezing (1)
- Vancomycin / administration & dosage (1)
- Vancomycin / chemistry (1)
- Vancomycin / pharmacology (1)
- Vascularization (1)
- Vaskularisation (1)
- Verbundwerkstoff (1)
- WST test (1)
- Wasserlösliche Polymere (1)
- Wirkstoff-Träger-System (1)
- Wirkstofffreisetzung (1)
- ZIP (1)
- acrylate-endcapped urethane-based polymer (AUP) (1)
- actin (1)
- acute myeloid leukaemia (1)
- adhesion dynamics (1)
- adipose tissue (1)
- adipose-derived stromal cells (1)
- agarose (1)
- alginate (1)
- alveolar‐capillary barrier (1)
- amoeboid cell migration (1)
- animal model (1)
- anisotropic porous structures (1)
- anti-bacterial agents / administration & dosage (1)
- anti-bacterial agents / chemistry (1)
- anti-bacterial agents / pharmacology (1)
- antibacterial (1)
- antibakteriell (1)
- arthritis (1)
- artificial bones (1)
- astrocytes (1)
- atomic force microscopy (1)
- axial vascularization (1)
- azlactone (1)
- balloon kyphoplasty (1)
- bending strength (1)
- bio-printability (1)
- bioceramic (1)
- bioceramics (1)
- biocompatible Materials (1)
- biodegradable polymer (1)
- biodegradable polymers (1)
- biofabricated vascular graft (1)
- bioinorganic (1)
- bioinspired interface (1)
- bioinspired membrane (1)
- biological models (1)
- biomaterial ink (1)
- biomechanical evaluation (1)
- biomechanics (1)
- biomedical engineering (1)
- biophysics (1)
- biosensor (1)
- biosensors (1)
- blood-plasma (1)
- bohrbar (1)
- bone and cartilage tissue engineering (1)
- bone critical size defect (1)
- bone graft substitutes (1)
- bone replacement material (1)
- bone wax (1)
- bone wires (1)
- brain cancer (1)
- breast cancer model (1)
- brushite cement (1)
- calcaneus (1)
- calcium phosphate cements (1)
- calcium-phosphate (1)
- calciumhydroxide (1)
- carbon fiber reinforcement (1)
- cardiovascular pharmacology (1)
- cartilage repair (1)
- cell coagulation (1)
- cell counting (1)
- cell elongation (1)
- cell guidance (1)
- cell migration (1)
- cell morphology (1)
- cell printing (1)
- cell self-assembled monolayers (1)
- cell transplantation (1)
- cell viability (1)
- cement (1)
- centrifugally casting (1)
- ceramic polymer composite (1)
- ceramics (1)
- chemical crosslinking (1)
- chemokines (1)
- chemoselective (1)
- chemosensitivity (1)
- chondrocyte (1)
- chondrocytes (1)
- chondroprogenitors (1)
- click chemistry (1)
- co-culture (1)
- coating (1)
- coatings (1)
- cochlea (1)
- collagen (1)
- collagen sponge (1)
- combination of physical vapor deposition and electrochemical etching (1)
- composite material (1)
- compressive strength (1)
- connective tissue (1)
- crosslinked coating (1)
- cryostructured scaffolds (1)
- cyclic mechanical stretch (1)
- cyclic stretch (1)
- cyclic testing (1)
- cyto-compatibility (1)
- cytotoxicity (1)
- damage tolerant cement (1)
- deafness (1)
- defects (1)
- defined humanized test system (1)
- definition (1)
- degradable bone substitutes (1)
- degradable implant (1)
- degradation (1)
- detachment force quantification (1)
- dicalcium phosphate cement (1)
- differentation (1)
- digitization (1)
- dihydrate cement (1)
- directional solidification (1)
- disease models (1)
- drillability (1)
- drillable (1)
- drillable bone cement (1)
- drop on demand (1)
- drug delivery (1)
- drug liberation (1)
- drug release (1)
- dual abbindend (1)
- durotaxis (1)
- electroactive (1)
- electroactive polymers (1)
- electron microscopy (1)
- electrospinning (1)
- electrospun fibers (1)
- eletrhydrodynamic (1)
- embedded templating (1)
- endothelial progenitor cells (1)
- expression (1)
- extrusion of hiMPC-containing bioinks alginate + collagen type I (1)
- extrusion-based 3D printing (1)
- factor-I (1)
- farringtonite (1)
- fiber (1)
- fiber reinforcement (1)
- fibers (1)
- fiber–matrix interaction (1)
- fixation (1)
- focal adhesions (1)
- force (1)
- fracture (1)
- free radical polymerization (1)
- functionalization (1)
- funktionale Präpolymere (1)
- gels (1)
- gels and hydrogels (1)
- gentamicin-loaded poly (methyl methacrylate) bone cement (1)
- granules (1)
- growth (1)
- guided bone regeneration (1)
- heart-failure (1)
- hemocompatibility (1)
- heterotypic scaffold design (1)
- human iPSC-derived mesodermal cells (hiMPCs) (1)
- human macrophages (1)
- human neutrophil elastase (HNE) (1)
- hybrid fabrication (1)
- hybrid materials (1)
- hybrid polymers (1)
- hydraulic reactivity (1)
- hydrogel formation (1)
- hydrophilic polymers (1)
- hydroxyapatite (1)
- hypoxia (1)
- imaging agents (1)
- immunomodulation (1)
- implant (1)
- implants (1)
- in vitro cell‐stretch model (1)
- in-vivo Micro-Computed Tomography (1)
- inflammatory response (1)
- inner ear (1)
- inositol hexaphosphate (1)
- intercellular adhesion (1)
- interface control (1)
- iron release (1)
- lectin (1)
- left-ventricular function (1)
- load to failure testing (1)
- lung cell model (1)
- macrophage polarization (1)
- macrophages (1)
- magnetic properties (1)
- magnetoactive materials (1)
- materials testing (1)
- mature cell-cell contacts (1)
- mechanical activation (1)
- mechanical performance (1)
- mechanical properties (1)
- mechanical reinforcement (1)
- medical device (1)
- medical-grade poly(ε-caprolactone) (1)
- medicine (1)
- melanoma (1)
- melt electrowriting (1)
- melt electrofibrillation (1)
- melt electrospinning (1)
- mesenchymal stem cells (1)
- microfibers (1)
- microfibres (1)
- microfluidics (1)
- microstructures (1)
- microvasculature (1)
- migration (1)
- minipig (1)
- modelling (1)
- morphology controls (1)
- mucin (1)
- multilayered vessel wall with intimate, media and adventitia (1)
- nanofibers (1)
- nanostructures (1)
- nanotopographical surfaces (1)
- native chemical ligation (1)
- networks (1)
- neurite growth (1)
- organ-on-a-chip (1)
- organoids (1)
- osseointegration (1)
- osteoblasts (1)
- osteochondral defect (1)
- osteoporosis (1)
- oxidation (1)
- particle study (1)
- peptide conjugation (1)
- peptide immobilization (1)
- phase conversion (1)
- photo-crosslinking (1)
- photopolymerization (1)
- physicochemical characterization (1)
- plasticizers (1)
- platelet-adhesion (1)
- platelets (1)
- poly(2-ethyl-2-oxazoline) (1)
- poly(2-oxazoline)s (1)
- poly(ethylene glycol) (1)
- poly(glycidol) (1)
- poly(lactic-co-glycolic acid) (1)
- poly(lactide-co-glycolide) (1)
- polyacrylic acid (1)
- polyethylene glycol (1)
- polyethylenglykole (1)
- polyglycidol (1)
- polylactid (1)
- polymer (1)
- polymer-analogue functionalization (1)
- polymeric matrix (1)
- polymers (1)
- polyoxazoline (1)
- polyoxazolines (1)
- porosity (1)
- postsurgical adhesion (1)
- pre-crosslinking (1)
- premixed (1)
- primary vascular smooth muscle‐like cells (vSMCs) (1)
- proliferation (1)
- prostheses and implants (1)
- protein adsorption (1)
- präfabriziert (1)
- radiopacity (1)
- rat model (1)
- recruitment (1)
- remodelling (1)
- repair (1)
- rhBMP–2 (1)
- ring opening polymerisation (1)
- ring-opening polymerization (1)
- sPEG (1)
- sacrificial printing (1)
- sanders (1)
- scaffolds (1)
- screw (1)
- self-assembled monolayers (1)
- serial block face EM (1)
- setting reaction (1)
- shear stress (1)
- shear thinning (1)
- signaling (1)
- silicones (1)
- sodium alginate (1)
- solution electrospinning (1)
- spheroids (1)
- spinning (1)
- stanfieldite (1)
- starPEG (1)
- starPEG hydrogel (1)
- stem cells (1)
- stimulation (1)
- stress (1)
- subcutaneous implanation (1)
- sugar glass printing (1)
- surface coating (1)
- surface functionalisation (1)
- surface functionalization (1)
- surfaces (1)
- sutures (1)
- synbones (1)
- synergistic reinforcement (1)
- synthetic hydrogels (1)
- systematic investigations (1)
- tension (1)
- tethering (1)
- thermoresponsive hydrogel (1)
- thrombin (1)
- thrombosis (1)
- tibial head depression fracture (1)
- tissue morphogenesis (1)
- tissue regeneration (1)
- topotaxis (1)
- total joint arthroplasty (1)
- total knee arthroplasty (1)
- traction (1)
- tranexamic acid (1)
- transforming growth factor-beta 1 (1)
- transplantation (1)
- tubular constructs (1)
- tumor heterogeneity (1)
- tunable ultra‐thin biphasic membrane (1)
- unidirectional freezing (1)
- vascular biofabrication (1)
- vascular network and hierarchical organized vessels (1)
- x-ray micro computed tomography (1)
- zinc (1)
- zonal (1)
- zonal construct (1)
- α-tricalcium phosphate (1)
Institute
- Abteilung für Funktionswerkstoffe der Medizin und der Zahnheilkunde (122) (remove)
Sonstige beteiligte Institutionen
Metals are the most used materials for implant devices, especially in orthopedics, but despite their long history of application issues such as material failure through wear and corrosion remain unsolved leading to a certain number of revision surgeries. Apart from the problems associated with insufficient material properties, another serious issue is an implant associated infection due to the formation of a biofilm on the surface of the material after implantation. Thus, improvements in implant technology are demanded, especially since there is a projected rise of implants needed in the future. Surface modification methods such as physical vapour deposition (PVD), oxygen diffusion hardening and electrochemical anodization have shown to be efficient methods to improve the surfaces of metallic bulk materials regarding biomedical issues. This thesis was focused on the development of functional PVD coatings that are suitable for further treatment with surface modification techniques originally developed for bulk metals. The aim was to precisely adjust the surface properties of the implant according to the targeted application to prevent possible failure mechanisms such as coating delamination, wear or the occurrence of post-operative infections.
Initially, tantalum layers with approx 5 µm thickness were deposited at elevated substrate temperatures on cp Ti by RF magnetron sputtering. Due to the high affinity of tantalum to oxygen, these coatings are known to provide a self healing capacity since the rapid oxide formation is known to close surface cracks. Here, the work aimed to reduce the abrupt change of mechanical properties between the hard and brittle coating and the ductile substrate by creating an oxygen diffusion zone. It was found that the hardness and adhesion could be significantly increased when the coatings were treated afterwards by oxygen diffusion hardening in a two step process. Firstly, the surface was oxidized at a pressure of 6.7•10-3 mbar at 350 450 °C, followed by 1-2 h annealing in oxygen-free atmosphere at the same temperature leading to a diffusion of oxygen atoms into deeper parts of the substrate as proved by X-ray diffraction (XRD) analysis. The hereby caused mechanical stress in the crystal lattice led to an increase in Vickers hardness of the Ta layers from 570 HV to over 900 HV. Investigations into the adhesion of oxygen diffusion treated samples by Rockwell measurements demonstrated an increase of critical force for coating delamination from 12 N for untreated samples up to 25 N for diffusion treated samples.
In a second approach, the development of modular targets aimed to produce functional coatings by metallic doping of titanium with biologically active agents. This was demonstrated by the fabrication of antimicrobial Ti(Ag) coatings using a single magnetron sputtering source equipped with a titanium target containing implemented silver modules under variation of bias voltage and substrate temperature. The deposition of both Ti and Ag was confirmed by X-ray diffraction and a clear correlation between the applied sputtering parameters and the silver content of the coatings was demonstrated by ICP-MS and EDX. Surface-sensitive XPS measurements revealed that higher substrate temperatures led to an accumulation of Ag in the near-surface region, while the application of a bias voltage had the opposite effect. SEM and AFM microscopy revealed that substrate heating during film deposition supported the formation of even and dense surface layers with small roughness values, which could even be enforced by applying a substrate bias voltage. Additional elution measurements using ICP-MS showed that the release kinetics depended on the amount of silver located at the film surface and hence could be tailored by variation of the sputter parameters.
In a final step, the applied Ti and Ti(Ag) coatings deposited on cp Ti, stainless steel (316L) and glass substrates were subsequently nanostructured using a self-ordering process induced by electrochemical anodization in aqueous fluoride containing electrolytes. SEM analysis showed that nanotube arrays could be grown from the Ti and Ti(Ag) coatings deposited at elevated temperatures on any substrate, whereby no influence of the substrate on nanotube morphology could be observed. EDX measurements indicated that the anodization process led to the selective etching of Ti from Ti(Ag) coating. Further experiments on coatings deposited on glass surfaces revealed that moderate substrate temperatures during deposition resulting in smooth Ti layers as determined by AFM measurements, are favorable for the generation of highly ordered nanotube arrays. Such arrays exhibited superhydrophilic behavior as proved by contact angle measurements. XRD analysis revealed that the nanostructured coatings were amorphous after anodization but could be crystallized to anatase structure by thermal treatment at temperatures of 450°C.
The key hypothesis of this work represented the question, if mimicking the zonal composition and structural porosity of musculoskeletal tissues influences invading cells positively and leads to advantageous results for tissue engineering. Conventional approaches in tissue engineering are limited in producing monolithic “scaffolds” that provide locally variating biological key signals and pore architectures, imitating the alignment of collagenous fibres in bone and cartilage tissues, respectively. In order to fill this gap in available tissue engineering strategies, a new fabrication technique was evolved for the production of scaffolds to validate the hypothesis.
Therefore, a new solidification based platform procedure was developed. This process comprises the directional solidification of multiple flowable precursors that are “cryostructured” to prepare a controlled anisotropic pore structure. Porous scaffolds are attained through ice crystal removal by lyophilisation. Optionally, electrostatic spinning of polymers may be applied to provide an external mesh on top or around the scaffolds. A consolidation step generates monolithic matrices from multi zonal structures. To serve as matrix for tissue engineering approaches or direct implantation as medical device, the scaffold is sterilized.
An Adjustable Cryostructuring Device (ACD) was successively developed; individual parts were conceptualized by computer aided design (CAD) and assembled. During optimisation, a significant performance improvement of the ACDs accessible external temperature gradient was achieved, from (1.3 ± 0.1) K/mm to (9.0 ± 0.1) K/mm. Additionally, four different configurations of the device were made available that enabled the directional solidification of collagenous precursors in a highly controlled manner with various sample sizes and shapes.
By using alginate as a model substance the process was systematically evaluated. Cryostructuring diagraphs were analysed yielding solidification parameters, which were associated to pore sizes and alignments that were determined by image processing. Thereby, a precise control over pore size and alignment through electrical regulation of the ACD could be demonstrated.
To obtain tissue mimetic scaffolds for the musculoskeletal system, collagens and calcium phosphates had to be prepared to serve as raw materials. Extraction and purification protocols were established to generate collagen I and collagen II, while the calcium phosphates brushite and hydroxyapatite were produced by precipitation reactions.
Besides the successive augmentation of the ACD also an optimization of the processing steps was crucial. Firstly, the concentrations and the individual behaviour of respective precursor components had to be screened. Together with the insights gained by videographic examination of solidifying collagen solutions, essential knowledge was gained that facilitated the production of more complex scaffolds. Phenomena of ice crystal growth during cryostructuring were discussed. By evolutionary steps, a cryostructuring of multi-layered precursors with consecutive anisotropic pores could be achieved and successfully transferred from alginate to collagenous precursors. Finally, very smooth interfaces that were hardly detectable by scanning electron microscopy (SEM) could be attained. For the used collagenous systems, a dependency relation between adjustable processing parameters and different resulting solidification morphologies was created.
Dehydrothermal-, diisocyanate-, and carbodiimide- based cross linking methods were evaluated, whereby the “zero length” cross linking by carbodiimide was found to be most suitable. Afterwards, a formulation for the cross linking solution was elaborated, which generated favourable outcomes by application inside a reduced pressure apparatus. As a consequence, a pore collapse during wet chemical cross linking could be avoided.
Complex monolithic scaffolds featuring continuous pores were fabricated that mimicked structure and respective composition of different areas of native tissues by the presence of biochemical key stimulants. At first, three types of bone scaffolds were produced from collagen I and hydroxyapatite with appropriate sizes to fit critical sized defects in rat femurs. They either featured an isotropic or anisotropic porosity and partly also contained glycosaminoglycans (GAGs). Furthermore, meniscus scaffolds were prepared by processing two precursors with biomimetic contents of collagen I, collagen II and GAGs. Here, the pore structures were created under boundary conditions, which allowed an ice crystal growth that was nearly orthogonal to the external temperature gradient. Thereby, the preferential alignment of collagen fibres in the natural meniscus tissue could be mimicked. Those scaffolds owned appropriate sizes for cell culture in well plates or even an authentic meniscus shape and size. Finally, osteochondral scaffolds, sized to either fit well plates or perfusion reactors for cell culture, were fabricated to mimic the composition of subchondral bone and different cartilage zones. Collagen I and the resorbable calcium phosphate brushite were used for the subchondral zone, whereas the cartilage zones were composed out of collagen I, collagen II and tissue mimetic contents of GAGs. The pore structure corresponded to the one that is dominating the volume of natural osteochondral tissue.
Energy dispersive X-ray spectroscopy (EDX) and SEM were used to analyse the composition and pore structure of the individual scaffold zones, respectively. The cross section pore diameters were determined to (65 ± 25) µm, (88 ± 35) µm and(93 ± 42) µm for the anisotropic, the isotropic and GAG containing isotropic bone scaffolds. Furthermore, the meniscus scaffolds showed pore diameters of (93 ± 21) µm in the inner meniscus zone and (248 ± 63) µm inside the outer meniscus zone. Pore sizes of (82 ± 25) µm, (83 ± 29) µm and (85 ± 39) µm were present inside the subchondral, the lower chondral and the upper chondral zone of osteochondral scaffolds. Depending on the fabrication parameters, the respective scaffold zones were also found to feature a specific micro- and nanostructure at their inner surfaces.
Degradation studies were carried out under physiological conditions and resulted in a mean mass loss of (0.52 ± 0.13) %, (1.56 ± 0.10) % and (0.80 ± 0.10) % per day for bone, meniscus and osteochondral scaffolds, respectively. Rheological measurements were used to determine the viscosity changes upon cooling of different precursors. Micro computer tomography (µ-CT) investigations were applied to characterize the 3D microstructure of osteochondral scaffolds. To obtain an osteochondral scaffold with four zones of tissue mimetic microstructure alignment, a poly (D, L-lactide-co-glycolide) mesh was deposited on the upper chondral zone by electrostatic spinning. In case of the bone scaffolds, the retention / release capacity of bone morphogenetic protein 2 (BMP-2) was evaluated by an enzyme linked immunosorbent assay (ELISA). Due to the high presence of attractive BMP binding sites, only less than 0.1 % of the initially loaded cytokine was released. The suitability of combining the cryostructuring process with 3D powder printed calcium phosphate substrates was evaluated with osteochondral scaffolds, but did not appear to yield more preferable results than the non-combined approach.
A new custom build confined compression setup was elaborated together with a suitable evaluation procedure for the mechanical characterisation under physiological conditions. For bone and cartilage scaffolds, apparent elastic moduli of (37.6 ± 6.9) kPa and (3.14 ± 0.85) kPa were measured. A similar behaviour of the scaffolds to natural cartilage and bone tissue was demonstrated in terms of elastic energy storage. Under physiological frequencies, less than 1.0 % and 0.8 % of the exerted energy was lost for bone and cartilage scaffolds, respectively. With average relaxation times of (0.613 ± 0.040) sec and (0.815 ± 0.077) sec, measured for the cartilage and bone scaffolds, they respond four orders of magnitude faster than the native tissues. Additionally, all kinds of produced scaffolds were able to withstand cyclic compression at un-physiological frequencies as high as 20 Hz without a loss in structural integrity.
With the presented new method, scaffolds could be fabricated whose extent in mimicking of native tissues exceeded the one of scaffolds producible by state of the art methods. This allowed a testing of the key hypothesis: The biological evaluation of an anisotropic pore structure in vivo revealed a higher functionality of immigrated cells and led finally to advantageous healing outcomes. Moreover, the mimicking of local compositions in combination with a consecutive anisotropic porosity that approaches native tissue structures could be demonstrated to induce zone specific matrix remodelling in stem cells in vitro. Additionally, clues for a zone specific chondrogenic stem cell differentiation were attained without the supplementation of growth factors.
Thereby, the hypothesis that an increased approximation of the hierarchically compositional and structurally anisotropic properties of musculoskeletal tissues would lead to an improved cellular response and a better healing quality, could be confirmed. With a special focus on cell free in situ tissue engineering approaches, the insights gained within this thesis may be directly transferred to clinical regenerative therapies.
Chemoselective poly(oxazolines) (POx) and poly[(oligo ethylene glycol) acrylates] were synthesized. An initiator was produced for the preparation of poly(oxazoline)s capable of participating in click chemistry reactions which allows the functionalization of the polymer at the α terminus which was confirmed by 1H NMR spectroscopy. The initiator was used for the polymerization of hydrophilic 2 methyl 2 oxazoline (MeOx), whereby chemoselective, alkyne functionalized polymers could be prepared for Cu-catalyzed azide–alkyne cycloaddition. The desired molecular weight could be achieved through the living, ring opening cationic polymerization and was confirmed by 1H NMR, SEC and MALDI ToF measurements. Polymers were terminated with piperidine if no further functionalization was needed, or with an ester derivate for enabling amine attachment in a subsequent step. In addition, polymers were functionalized by termination with NaN3 in order to provide the counterpart to the azide–alkyne reaction. IR spectroscopy was suitable for the azide detection. The coupling of polymers showed the reactivity and could be confirmed by SEC, 1H NMR and IR spectroscopy.
The composition of cysteine functionalized POx was completed by thiol–ene chemistry. Since the commercially available iso 2 propyl 2 oxazoline is not available for the cationic polymerization, 2 butenyl and 2 decenyl 2 oxazoline (ButenOx and DecenOx) were first prepared. The synthesis of both copolymers, based on MeOx could be confirmed by 1H NMR as well as with SEC, whereby narrow distributions with dispersities of 1.06 could be achieved. The cysteine functionalization of the copolymers was enabled by the creation of a thiazolidine component which could be synthesized by acetal and formyl protection of cysteine and subsequent functionalization with a thiol. The component enabled the reaction with a polymer by thiol–ene reaction which was started by the addition of dimethoxyphenyl-acetophenone and was catalyzed by irradiation with UV light. Both copolymers, with a shorter (polymers with BuenOx) and longer (polymers with DecenOx) hydrophobic sidechain could be functionalized. 1H NMR spectroscopic analysis showed a quantitative reaction with the thiazolidine derivate. After deprotection by acidic workup the desired, cysteine functionalized polymer could be isolated. Quantification of cysteine functions was ensured by a modified TNBSA assay, whereby the thiols were first oxidized in order to confirm an independent measurement of amine functions. Both, the TNBSA assay as well as the NMR measurement showed the desired number of cysteine residues.
The cytotoxicity of functionalized polymers with different compositions was tested by a luminescent cell viability assay (LCVA). Both, the amount of cysteine functions (5–10%) in the copolymers as well as the length of the hydrophobic side chain were varied. All polymers did not show cytotoxicity up to concentrations of 10 mg∙mL-1. The cell activity and cell numbers only decreased below 50% and 20% respectively, when copolymers with 5% cysteine and longer sidechains were measured, which was attributed to a contamination of the sample itself. The cooperation partner performed Native Chemical Ligation (NCL) with model peptides and purified the products by HPLC. A sterically non demanding peptide was synthesized, consisting of an aromatic amino acid and four glycine units. The aromatic unit was used for the quantification of the polymer–peptide conjugate in the 1H NMR spectroscopy. A polymer having five cysteine side chains has been fully implemented by NCL to a conjugate of one polymer with five peptides. A sterically more demanding peptide was additionally used and MALDI ToF measurements confirmed the successful conjugation.
Furthermore the cysteine functionalized polymer was used for nanogel synthesis. The thiol of the cysteine function was oxidized in an inverse mini-emulsion by H2O2, resulting in nanogels (~500 nm) which could be confirmed by SEM, AFM, DLS and NTA measurements.
Besides POx, oligo (ethylene glycol)acrylates (OEGA) were polymerized; by copolymerization with the reactive pentafluorophenyl acrylate (PFPA) reactive and amphiphilic polymers were obtained. The synthesis of PFPA could be confirmed spectroscopically by 1H , 19F NMR, and by FT IR. Copolymers were synthesized by RAFT polymerization with narrow dispersities. Functionalization with an amine functionalized thiazolidine led to a hydrophilic cysteine functionalized polymer after acidic deprotection. Apart from this polymer, a thioester functionalization was successfully performed by reaction of the active polymer with a cyclic amine functionalized thioester which does not release a toxic by product (such as the resulting thiol) during NCL and thus features a very high potential to replace former thioester.
Background
There is a need to establish more cell lines from breast tumors in contrast to immortalized cell lines from metastatic effusions in order to represent the primary tumor and not principally metastatic biology of breast cancer. This investigation describes the simultaneous isolation, characterization, growth and function of primary mammary epithelial cells (MEC), mesenchymal cells (MES) and adipose derived stem cells (ADSC) from four normal breasts, one inflammatory and one triple-negative ductal breast tumors.
Methods
A total of 17 cell lines were established and gene expression was analyzed for MEC and MES (n = 42) and ADSC (n = 48) and MUC1, pan-KRT, CD90 and GATA-3 by immunofluorescence. DNA fingerprinting to track cell line identity was performed between original primary tissues and isolates. Functional studies included ADSC differentiation, tumor MES and MEC invasion co-cultured with ADSC-conditioned media (CM) and MES adhesion and growth on 3D-printed scaffolds.
Results
Comparative analysis showed higher gene expression of EPCAM, CD49f, CDH1 and KRTs for normal MEC lines; MES lines e.g. Vimentin, CD10, ACTA2 and MMP9; and ADSC lines e.g. CD105, CD90, CDH2 and CDH11. Compared to the mean of all four normal breast cell lines, both breast tumor cell lines demonstrated significantly lower ADSC marker gene expression, but higher expression of mesenchymal and invasion gene markers like SNAI1 and MMP2. When compared with four normal ADSC differentiated lineages, both tumor ADSC showed impaired osteogenic and chondrogenic but enhanced adipogenic differentiation and endothelial-like structures, possibly due to high PDGFRB and CD34. Addressing a functional role for overproduction of adipocytes, we initiated 3D-invasion studies including different cell types from the same patient. CM from ADSC differentiating into adipocytes induced tumor MEC 3D-invasion via EMT and amoeboid phenotypes. Normal MES breast cells adhered and proliferated on 3D-printed scaffolds containing 20 fibers, but not on 2.5D-printed scaffolds with single fiber layers, important for tissue engineering.
Conclusion
Expression analyses confirmed successful simultaneous cell isolations of three different phenotypes from normal and tumor primary breast tissues. Our cell culture studies support that breast-tumor environment differentially regulates tumor ADSC plasticity as well as cell invasion and demonstrates applications for regenerative medicine.
The development and formulation of printable inks for extrusion-based 3D bioprinting has been a major challenge in the field of biofabrication. Inks, often polymer solutions with the addition of crosslinking to form hydrogels, must not only display adequate mechanical properties for the chosen application but also show high biocompatibility as well as printability. Here we describe a reproducible two-step method for the assessment of the printability of inks for bioprinting, focussing firstly on screening ink formulations to assess fibre formation and the ability to form 3D constructs before presenting a method for the rheological evaluation of inks to characterise the yield point, shear thinning and recovery behaviour. In conjunction, a mathematical model was formulated to provide a theoretical understanding of the pressure-driven, shear thinning extrusion of inks through needles in a bioprinter. The assessment methods were trialled with a commercially available crème, poloxamer 407, alginate-based inks and an alginate-gelatine composite material. Yield stress was investigated by applying a stress ramp to a number of inks, which demonstrated the necessity of high yield for printable materials. The shear thinning behaviour of the inks was then characterised by quantifying the degree of shear thinning and using the mathematical model to predict the window of printer operating parameters in which the materials could be printed. Furthermore, the model predicted high shear conditions and high residence times for cells at the walls of the needle and effects on cytocompatibility at different printing conditions. Finally, the ability of the materials to recover to their original viscosity after extrusion was examined using rotational recovery rheological measurements. Taken together, these assessment techniques revealed significant insights into the requirements for printable inks and shear conditions present during the extrusion process and allow the rapid and reproducible characterisation of a wide variety of inks for bioprinting.
Calcium phosphate biocements are inherently brittle materials due to their ceramic nature. Hence, currently applied cement formulations are only indicated for non-load bearing application sites. An approach to reduce cement brittleness is based on the use of cement – polymer composites, which combine the flexibility of a polymeric phase with the hardness and compression strength of a cement matrix. Here, a relatively new strategy is the use of “dual-setting” cements, in which the polymeric phase is simultaneously build up from monomers or prepolymers during cement setting. This approach largely maintains basic properties of the fresh paste such as rheology or setting time. Previous works on such dual setting cements were dealing with a radical polymerization reaction to create the polymeric network. This type of reaction requires the addition of a suitable initiator system (e.g. a tertiary amine in conjunction with ammonium peroxosulfate), which are often cytotoxic and may interfere with the cement setting conditions. The current thesis dealt with alternative strategies, in which the cross-linking and gelation of the second (polymeric or inorganic) cement phase is initiated by the chemical conditions of the setting reaction such that no additional initiator has to be added to the cement paste.
In a first approach a six armed star molecule functionalized with isocyanate groups as reactive termini (NCO–sP(EO-stat-PO)) was used to build up a hydrogel matrix, which was then subsequently mineralized with hydroxyapatite nanocrystals following the hydrolysis of incorporated -tricalcium phosphate particles. The stimulus to initiate hydrogel cross-linking are water molecules, which subsequently hydrolyzed isocyanate groups to amines, which then cross-linked with unreacted isocyanate to form urea-bonds. Here, it was possible to show the advantages features of a dual setting system in comparison to the simple combination of hydrogels with unreactive filler particles. By the formation of the cement matrix within the hydrogel a strength improvement by the factor of 30 could be observed. Furthermore, by applying a dual setting system higher mineral concentrations are realizable. The mechanical properties such as elasticity, compression strength and E-modulus of a composite with 30 wt% NCO–sP(EO-stat-PO) were found to be similar to the properties of cancellous bone.
With the motivation to develop a dual setting and resorbable cement, a brushite (CaHPO4·2H2O) forming cement was modified with a second inorganic silica based precursor. The latter was obtained by pre-hydrolysing tetraethyl orthosilicate (TEOS) under acidic conditions. This silica precursor was mixed with a cement powder composed of ß-tricalcium phosphate and monocalcium phosphate, whereas cement setting occurred by a dissolution–precipitation process to form a matrix of brushite. Simultaneously, the increase of the pH during setting from initially 1-2 to values > 4 initiated the condensation reaction of the hydrolysed TEOS. This resulted in an interpenetrating phase composite material in which the micropores of the cement were filled with the nanoporous silica gel. This resulted in a higher density and a compressive strength of 24 MPa, which is approximately 5-10 times higher than the CPC reference at the same powder to liquid ratio. The microporous character of the composites also altered the release of vancomycin as a model drug, whereby in contrast to the quantitative release from the CPC reference, approx. 25 % of the immobilised drug remained in the composite matrix. It was also observed, that a variation of the TEOS content in the composite enabled a control over cement phase composition to form either brushite, anhydrous monetite or a biphasic mixture of both. Cytocompatibility tests revealed that composites with the highest silicate content showed an increased cell proliferation compared to the silica-free brushite reference. Proliferation was found to be similar to a hydroxyapatite reference with a significant higher activity per cell. Mechanistically, the improved biological response could not be attributed to the released silicate ions, but to a decreased release of phosphate and adsorption of magnesium ions from the cell culture medium.
Finally, an investigated dual setting cement system was based on the combination of a brushite forming cement powder with an aqueous silk fibroin solution. Here, changes of both ion concentration and pH during cement setting were shown to build up an interpenetrating fibroin – brushite composite with combined properties of the elastic polymer and the rigid cement. Mechanistically, the low pH of the cement paste (2) as well as the free Ca2+ ions during setting resulted in a conformation change of the dissolved fibroin from random coil to ß-sheet structure. This leads to a rapid gelation and contraction of the fibroin phase with a self-densifying effect on the cement paste. The set composites showed typical ductile fracture behavior under dry testing conditions and a high elasticity under wet conditions with a mechanical strength nearly an order of magnitude higher than the fibroin free cement reference. Cell number and activity against MG63 cells were strongly increased on silk fibroin cement composite surfaces at later time points, which could be again attributed to a decreased ion release and adsorption compared to the fibroin free cements. This in turn slowed down the in vitro degradation of the CPC phase in such composites.
Intercellular adhesion plays a major role in tissue development and homeostasis. Yet, technologies to measure mature cell-cell contacts are not available. We introduce a methodology based on fluidic probe force microscopy to assess cell-cell adhesion forces after formation of mature intercellular contacts in cell monolayers. With this method we quantify that L929 fibroblasts exhibit negligible cell-cell adhesion in monolayers whereas human endothelial cells from the umbilical artery (HUAECs) exert strong intercellular adhesion forces per cell. We use a new in vitro model based on the overexpression of Muscle Segment Homeobox 1 (MSX1) to induce Endothelial-to-Mesenchymal Transition (EndMT), a process involved in cardiovascular development and disease. We reveal how intercellular adhesion forces in monolayer decrease significantly at an early stage of EndMT and we show that cells undergo stiffening and flattening at this stage. This new biomechanical insight complements and expands the established standard biomolecular analyses. Our study thus introduces a novel tool for the assessment of mature intercellular adhesion forces in a physiological setting that will be of relevance to biological processes in developmental biology, tissue regeneration and diseases like cancer and fibrosis.
Dicalcium phosphate cement preparation requires the addition of setting retarders to meet clinical requirements regarding handling time and processability. Previous studies have focused on the influence of different setting modifiers on material properties such as mechanical performance or injectability, while ignoring their influence on biological cement properties as they are used in low concentrations in the cement pastes and the occurrence of most compounds in human tissues. Here, analyses of both material and biological behavior were carried out on samples with common setting retardants (citric acid, sodium pyrophosphate, sulfuric acid) and novel (phytic acid). Cytocompatibility was evaluated by in vitro tests with osteoblastic (hFOB 1.19) and osteoclastic (RAW 264.7) cells. We found cytocompatibility was better for sodium pyrophosphate and phytic acid with a three-fold cell metabolic activity by WST-1 test, whereas samples set with citric acid showed reduced cell number as well as cell activity. The compressive strength (CS) of cements formed with phytic acid (CS = 13 MPa) were nearly equal to those formed with citric acid (CS = 15 MPa) and approximately threefold higher than for other setting retardants. Due to a proven cytocompatibility and high mechanical strength, phytic acid seems to be a candidate replacement setting retardant for dicalcium phosphate cements.
The main focus of this thesis was the processing of different calcium and magnesium phosphate cements together with an optimization of mechanical and biological properties. Therefore, different manufacturing techniques like 3D powder printing and centrifugally casting were employed for the fabrication of reinforced or biomedically improved implants.
One of the main problems during 3D powder printing is the low green strength of many materials, especially when they are only physically bonded and do not undergo a setting reaction. Such materials need post-treatments like sintering to exhibit their full mechanical performance. However, the green bodies have to be removed from the printer requiring a certain stability. With the help of fiber reinforcement, the green strength of printed gypsum samples could be increased by the addition of polymeric and glass fibers within the printing process. The results showed that fiber reinforcement during 3D powder printing is possible and opens up diverse opportunities to enhance the damage tolerance of green bodies as well as directly printed samples. The transfer to biomedically relevant materials like calcium and magnesium phosphate cements and biocompatible fibers would be the next step towards reinforced patient-specific implants.
In a second approach, centrifugally casting derived from construction industries was established for the fabrication of hollow bioceramic cylinders. The aim was the replacement of the diaphysis of long bones, which exhibit a tubular structure with a high density of cortical bone on the fringe. By centrifugation, cement slurries with and without additives could be fabricated to tubes. As a first establishment, the processing parameters regarding the material (e.g. cement composition) as well as the set-up (e.g. rotation times) had to be optimized for each system. In respect of mechanics, such tubes can keep up with 3D powder printed tubes, although the mechanical performance of 3D printed tubes is strongly dependent on printing directions. Additionally, some material compositions like dual setting systems cannot be fabricated by 3D powder printing. Therefore, a transfer of such techniques to centrifugally casting enabled the fabrication of tubular structures with an extremely high damage tolerance due to high deformation ability. A similar effect was achieved by fiber (mesh) addition, as already shown for 3D powder printing. Another possibility of centrifugally casting is the combination of different materials resulting in graded structures to adjust implant degradation or bone formation. This became especially apparent for the incorporation of the antibiotic vancomycin, which is used for the treatment of bacterial implant infections. A long-term release could be achieved by the entrapment of the drug between magnesium phosphate cement layers. Therefore, the release of the drug could be regulated by the degradation of the outer shell, which supports the release into an acidic bacterial environment. The centrifugally casting technique exhibited to be a versatile tool for numerous materials and applications including the fabrication of non-centrosymmetric patient-specific implants for the reconstruction of human long bones.
The third project aimed to manufacture strontium-substituted magnesium phosphate implants with improved biological behavior by 3D powder printing. As the promoting effect of strontium on bone formation and the inhibitory impact on bone resorption is already well investigated, the incorporation of strontium into a degradable magnesium phosphate cement promised a fast integration and replacement of the implant. Porous structures were obtained with a high pore interconnectivity that is favorable for cell invasion and bone ingrowth. Despite the porosity, the mechanical performance was comparable to pure magnesium phosphate cement with a high reliability of the printed samples as quantitatively determined by Weibull statistics. However, the biological testing was impeded by the high degradation rate and the relating ion release. The high release of phosphate ions into surrounding media and the detachment of cement particles from the surface inhibited osteoblast growth and activity. To distinguish those two effects, a direct and indirect cell seeding is always required for degradable materials. Furthermore, the high phosphate release compared to the strontium release has to be managed during degradation such that the adverse effect of phosphate ions does not overwhelm the bone promoting effect of the strontium ions.
The manufacturing techniques presented in this thesis together with the material property improvement offer a diverse tool box for the fabrication of patient-specific implants. This includes not just the individual implant shape but also the application like bone growth promotion, damage tolerance and local drug delivery. Therefore, this can act as the basis for further research on specific medical indications.
In order to mimic the extracellular matrix for tissue engineering, recent research approaches often involve 3D printing or electrospinning of fibres to scaffolds as cell carrier material. Within this thesis, a micron fibre printing process, called melt electrospinning writing (MEW), combining both additive manufacturing and electrospinning, has been investigated and improved. Thus, a unique device was developed for accurate process control and manufacturing of high quality constructs. Thereby, different studies could be conducted in order to understand the electrohydrodynamic printing behaviour of different medically relevant thermoplastics as well as to characterise the influence of MEW on the resulting scaffold performance.
For reproducible scaffold printing, a commonly occurring processing instability was investigated and defined as pulsing, or in extreme cases as long beading. Here, processing analysis could be performed with the aim to overcome those instabilities and prevent the resulting manufacturing issues. Two different biocompatible polymers were utilised for this study: poly(ε-caprolactone) (PCL) as the only material available for MEW until then and poly(2-ethyl-2-oxazoline) for the first time. A hypothesis including the dependency of pulsing regarding involved mass flows regulated by the feeding pressure and the electrical field strength could be presented. Further, a guide via fibre diameter quantification was established to assess and accomplish high quality printing of scaffolds for subsequent research tasks.
By following a combined approach including small sized spinnerets, small flow rates and high field strengths, PCL fibres with submicron-sized fibre diameters (fØ = 817 ± 165 nm) were deposited to defined scaffolds. The resulting material characteristics could be investigated regarding molecular orientation and morphological aspects. Thereby, an alignment and isotropic crystallinity was observed that can be attributed to the distinct acceleration of the solidifying jet in the electrical field and by the collector uptake. Resulting submicron fibres formed accurate but mechanically sensitive structures requiring further preparation for a suitable use in cell biology. To overcome this handling issue, a coating procedure, by using hydrophilic and cross-linkable star-shaped molecules for preparing fibre adhesive but cell repellent collector surfaces, was used.
Printing PCL fibre patterns below the critical translation speed (CTS) revealed the opportunity to manufacture sinusoidal shaped fibres analogously to those observed using purely viscous fluids falling on a moving belt. No significant influence of the high voltage field during MEW processing could be observed on the buckling phenomenon. A study on the sinusoidal geometry revealed increasing peak-to-peak values and decreasing wavelengths as a function of decreasing collector speeds sc between CTS > sc ≥ 2/3 CTS independent of feeding pressures. Resulting scaffolds printed at 100 %, 90 %, 80 % and 70 % of CTS exhibited significantly different tensile properties, foremost regarding Young’s moduli (E = 42 ± 7 MPa to 173 ± 22 MPa at 1 – 3 % strain). As known from literature, a changed morphology and mechanical environment can impact cell performance substantially leading to a new opportunity of tailoring TE scaffolds.
Further, poly(L-lactide-co-ε-caprolactone-co-acryloyl carbonate) as well as poly(ε-caprolactone-co-acryloyl carbonate) (PCLAC) copolymers could be used for MEW printing. Those exhibit the opportunity for UV-initiated radical cross-linking in a post-processing step leading to significantly increased mechanical characteristics. Here, single fibres of the polymer composed of 90 mol.% CL and 10 mol.% AC showed a considerable maximum tensile strength of σmax = 53 ± 16 MPa. Furthermore, sinusoidal meanders made of PCLAC yielded a specific tensile stress-strain characteristic mimicking the qualitative behaviour of tendons or ligaments. Cell viability by L929 murine fibroblasts and live/dead staining with human mesenchymal stem cells revealed a promising biomaterial behaviour pointing out MEW printed PCLAC scaffolds as promising choice for medical repair of load-bearing soft tissue.
Indeed, one apparent drawback, the small throughput similar to other AM methods, may still prevent MEW’s industrial application yet. However, ongoing research focusses on enlargement of manufacturing speed with the clear perspective of relevant improvement. Thereby, the utilisation of large spinneret sizes may enable printing of high volume rates, while downsizing the resulting fibre diameter via electrical field and mechanical stretching by the collector uptake. Using this approach, limitations of FDM by small nozzle sizes could be overcome. Thinking visionary, such printing devices could be placed in hospitals for patient-specific printing-on-demand therapies one day. Taking the evolved high deposition precision combined with the unique small fibre diameter sizes into account, technical processing of high performance membranes, filters or functional surface finishes also stands to reason.